IGF2 and hepatocellular carcinoma: Taken together, overexpression of IGF-2/INSR predicts the EMT phenotype and response to OSI-906 in HCC cell lines, and offers a method targeting IGF-1R, INSR, and HR due to the high degree of homology in the kinase domain of these receptors.